PHS
AMRX icon

PFM Health Sciences’s Amneal Pharmaceuticals AMRX Stock Holding History

PFM Health Sciences’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32M Sell
480,715
-449,381
-48% -$6.16M 0.71% 49
2026
Q1 		$11.6M Sell
930,096
-535,384
-37% -$7.19M 1.05% 32
2025
Q4 		$18.5M Buy
1,465,480
+1,109,662
+312% +$12.7M 1.84% 19
2025
Q3 		$3.56M Buy
+355,818
New +$3.19M 0.27% 58

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

PFM Health Sciences's AMRX Position: Q2 2026 in Review

PFM Health Sciences reduced its Amneal Pharmaceuticals (AMRX) stake by 48% in Q2 2026, selling an estimated $6.16M and leaving 480,715 shares worth $8.32M. The position accounts for 0.71% of the portfolio, ranked #49.

PFM Health Sciences first reported a position in AMRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $18.5M in Q4 2025. 308 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • PFM Health Sciences held 480,715 shares of Amneal Pharmaceuticals worth $8.32M as of Q2 2026.
  • PFM Health Sciences sold 449,381 Amneal Pharmaceuticals shares in Q2 2026, an estimated $6.16M.
  • Amneal Pharmaceuticals made up 0.71% of PFM Health Sciences's portfolio in Q2 2026, its #49 holding.
  • PFM Health Sciences first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • PFM Health Sciences's Amneal Pharmaceuticals position peaked at $18.5M in Q4 2025.
  • 308 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.